Marpai (MRAI) Competitors $1.24 -0.26 (-17.12%) As of 03:50 PM Eastern Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsHeadlinesInsider TradesSEC FilingsTrendsBuy This Stock MRAI vs. PIII, EUDA, ATPC, BDSX, BMGL, CCM, MGRX, BRTX, BGLC, and KDLYShould you be buying Marpai stock or one of its competitors? The main competitors of Marpai include P3 Health Partners (PIII), EUDA Health (EUDA), Agape ATP (ATPC), Biodesix (BDSX), Basel Medical Group (BMGL), Concord Medical Services (CCM), Mangoceuticals (MGRX), Biorestorative Therapies (BRTX), BioNexus Gene Lab (BGLC), and Kindly MD (KDLY). These companies are all part of the "healthcare" industry. Marpai vs. Its Competitors P3 Health Partners EUDA Health Agape ATP Biodesix Basel Medical Group Concord Medical Services Mangoceuticals Biorestorative Therapies BioNexus Gene Lab Kindly MD Marpai (NASDAQ:MRAI) and P3 Health Partners (NASDAQ:PIII) are both small-cap healthcare companies, but which is the superior stock? We will contrast the two companies based on the strength of their dividends, analyst recommendations, institutional ownership, valuation, earnings, profitability, risk and media sentiment. Do analysts rate MRAI or PIII? P3 Health Partners has a consensus price target of $16.25, indicating a potential upside of 76.63%. Given P3 Health Partners' stronger consensus rating and higher probable upside, analysts plainly believe P3 Health Partners is more favorable than Marpai.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Marpai 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00P3 Health Partners 1 Sell rating(s) 1 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.00 Which has stronger valuation & earnings, MRAI or PIII? Marpai has higher earnings, but lower revenue than P3 Health Partners. Marpai is trading at a lower price-to-earnings ratio than P3 Health Partners, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioMarpai$34.87M0.65-$28.75M-$0.87-1.43P3 Health Partners$1.50B0.04-$135.85M-$46.01-0.20 Is MRAI or PIII more profitable? P3 Health Partners has a net margin of -9.99% compared to Marpai's net margin of -85.70%. Marpai's return on equity of 0.00% beat P3 Health Partners' return on equity.Company Net Margins Return on Equity Return on Assets Marpai-85.70% N/A -100.23% P3 Health Partners -9.99%-183.60%-17.83% Which has more risk & volatility, MRAI or PIII? Marpai has a beta of 4.6, indicating that its share price is 360% more volatile than the S&P 500. Comparatively, P3 Health Partners has a beta of 0.84, indicating that its share price is 16% less volatile than the S&P 500. Do insiders & institutionals believe in MRAI or PIII? 49.8% of Marpai shares are held by institutional investors. Comparatively, 7.8% of P3 Health Partners shares are held by institutional investors. 46.1% of Marpai shares are held by insiders. Comparatively, 17.8% of P3 Health Partners shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term. Does the media favor MRAI or PIII? In the previous week, P3 Health Partners had 3 more articles in the media than Marpai. MarketBeat recorded 4 mentions for P3 Health Partners and 1 mentions for Marpai. P3 Health Partners' average media sentiment score of 0.62 beat Marpai's score of 0.00 indicating that P3 Health Partners is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Marpai 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral P3 Health Partners 0 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive SummaryP3 Health Partners beats Marpai on 9 of the 16 factors compared between the two stocks. Get Marpai News Delivered to You Automatically Sign up to receive the latest news and ratings for MRAI and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding MRAI and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart MRAI vs. The Competition Export to ExcelMetricMarpaihealth & allied services, not elsewhere classified IndustryBusiness SectorNASDAQ ExchangeMarket Cap$22.76M$68.10M$94.72T$10.23BDividend YieldN/AN/A2.85%4.69%P/E Ratio-0.470.5925.9526.57Price / Sales0.650.3974,612.55179.01Price / CashN/A2.8031.0862.20Price / Book-0.720.12185,976.796.53Net Income-$28.75M$43.11M$196.66M$275.87M7 Day Performance-18.75%-23.86%3,934,138.92%-1.40%1 Month Performance1.07%-19.86%3,941,497.61%5.16%1 Year Performance77.60%-14.29%7,807,336.70%31.51% Marpai Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)MRAIMarpaiN/A$1.24-17.1%N/A+111.3%$22.76M$34.87M-0.47150High Trading VolumePIIIP3 Health Partners2.8127 of 5 stars$8.94-7.0%$16.25+81.8%-43.7%$69.09M$1.50B-0.19500News CoverageAnalyst ForecastEUDAEUDA Health1.0847 of 5 stars$1.75+3.6%N/A-27.5%$62.61M$4.01M0.002ATPCAgape ATP0.6487 of 5 stars$1.27+1.2%N/A-32.0%$62.51M$1.32M-3.0940Analyst ForecastHigh Trading VolumeBDSXBiodesix3.2857 of 5 stars$7.55-2.5%$32.50+330.5%-76.1%$56.75M$71.32M-1.30220Analyst ForecastBMGLBasel Medical GroupN/A$1.82+1.7%N/AN/A$33.03MN/A0.0036Positive NewsAnalyst ForecastCCMConcord Medical Services0.7047 of 5 stars$6.13-6.7%N/A-18.4%$28.52M$52.60M0.00970Analyst ForecastGap DownMGRXMangoceuticals1.5172 of 5 stars$2.19+3.8%N/A-95.5%$22.23M$620K-0.573Analyst ForecastGap UpBRTXBiorestorative Therapies2.2139 of 5 stars$1.45flatN/A+3.1%$11.57M$605.20K-1.147Analyst ForecastGap UpBGLCBioNexus Gene Lab0.2103 of 5 stars$5.47flatN/A+31.2%$9.83M$9.51M0.0030Analyst ForecastKDLYKindly MDN/A$1.17+1.7%N/A-29.9%$7.05M$2.47M-1.52N/AHigh Trading Volume Related Companies and Tools Related Companies P3 Health Partners Competitors EUDA Health Competitors Agape ATP Competitors Biodesix Competitors Basel Medical Group Competitors Concord Medical Services Competitors Mangoceuticals Competitors Biorestorative Therapies Competitors BioNexus Gene Lab Competitors Kindly MD Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:MRAI) was last updated on 10/10/2025 by MarketBeat.com Staff From Our PartnersBitcoin grabs headlines, but smart money likes this tokenIf you're a futures trader (or want to be one), this could be the biggest shift you'll ever see in the prop fi...Neuro Street Trading Academy | SponsoredStunning new initiative unfolding in the White House?what I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | SponsoredURGENT: The Market's 3 Red Flags Are FlashingHere’s the uncomfortable truth: The smartest investors in the world are already preparing for a crash befor...StockEarnings | SponsoredU.S. Government Sparking Crypto RallyAltcoin ETFs could surge prices (do this now) My "Crypto Bull Run Millionaire Blueprint" breaks down exactl...Crypto 101 Media | Sponsored$100 Trillion “AI Metal” Found in American Ghost TownJeff Brown recently traveled to a ghost town in the middle of an American desert… To investigate what could...Brownstone Research | Sponsored1 Hour Once A DayMy top income trading expert, Dave Aquino, just released a 1-hour trading strategy designed specifically to he...Base Camp Trading | SponsoredClaim Your Share of $5.39 BILLION in AI Equity ChecksThe U.S. government just took advantage of Public Law 81-774 to crack down on AI companies... In turn, enfo...Angel Publishing | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Marpai, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Marpai With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
